Formation of secretory vesicles in the biosynthetic pathway  by Urbé, Sylvie et al.
 .Biochimica et Biophysica Acta 1358 1997 6–22
Review
Formation of secretory vesicles in the biosynthetic pathway
Sylvie Urbe, Sharon A. Tooze ), Francis A. Barr´
Imperial Cancer Research Fund, P.O. Box 123, London WC2A 3PX, UK
Received 26 November 1996; revised 19 March 1997; accepted 20 March 1997
Keywords: Secretion; Vesicle formation; Coat protein; ADP-ribolysation factor; Secretory granule
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2. The secretory pathway . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
3. COP I- and COP II-coated vesicle formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
3.1. COP I-coated vesicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
3.2. COP II-coated vesicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.3. ARF and SARI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
3.4. Cargo and selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
3.5. Cargo and the site of bud formation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
4. Formation of regulated secretory vesicles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
4.1. Aggregation of soluble secretory proteins as a means topromote sorting . . . . . . . . . . . . 12
4.2. Sorting signals as a means to promote sorting. . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
4.3. The role of GTP-binding proteins in secretory granuleformation . . . . . . . . . . . . . . . . 15
4.4. The role of phosphatidylinositide metabolism and secretorygranule formation . . . . . . . . 15
4.5. Post-TGN sorting and vesicle formation from the ISG . . . . . . . . . . . . . . . . . . . . . . 16
5. Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Abbreviations: ER, endoplasmic reticulum; TGN, trans-Golgi network; ISG, immature secretory granule; MPR, mannose-6-phosphate
receptor; ARF, ADP-ribosylation factor; COP, coat protein; GAP, GTPase activating protein; GEF, guanine nucleotide exchange factor;
PLD, phospholipase D; CgA, chromogranin A; CgB, chromogranin B; SgII, secretogranin II; PC, prohormone convertase; POMC,
pro-opiomelanocorticotropin; ACTH, adrenocorticotrophic hormone; MSH, melanocyte stimulating hormone; GH, growth hormone; PRL,
prolactin; ELH, egg-laying hormone; PtdIns, phosphatidylinositol; PITP, phosphatidylinositol transfer protein; DTT, dithiothreitol.
) Corresponding author. Fax q44 171 269-3417.
0167-4889r97r$17.00 q 1997 Elsevier Science B.V. All rights reserved.
 .PII S0167-4889 97 00050-5
( )S. Urbe et al.rBiochimica et Biophysica Acta 1358 1997 6–22´ 7
1. Introduction
It is well over 30 years ago since Caro and Palade
 . w x1964 1 first described vesicular transport interme-
diates in pancreatic acinar cells in which metaboli-
cally labeled proteins were detected by autoradiog-
raphy before being secreted into the lumen of the
acini. The dense core granules of the exocrine pan-
creas were extremely well suited for microscopical
analysis due to their abundance and distinct morpho-
logical features. Since then a number of increasingly
elusive types of transport vesicles have been de-
scribed, isolated and analyzed to the effect that the
molecular basis of the formation and consumption of
these vesicles is now progressively being unravelled.
A combination of biochemical and genetic ap-
proaches has led to the identification of structural as
well as regulatory components of secretory vesicles
w x2 . Although we will in some cases refer to impor-
tant new advances in vesicular transport along the
endocytic pathway, this review will mainly focus on
the formation of secretory vesicles.
2. The secretory pathway
The majority of secretory proteins enter the en-
domembrane system of the eukaryotic cell coinci-
dently with or shortly after their synthesis as they are
translocated into the lumen of the endoplasmic reticu-
 .lum ER . On their way to the plasma membrane
these proteins traverse a series of membrane-bounded
compartments in which numerous biochemical modi-
fications take place. Transport from one compartment
to another is accomplished through vesicular interme-
diates that form at the ‘donor’ compartment and are
then targeted to and fuse with the appropriate ‘accep-
w xtor’ compartment 2,3 . The formation of these trans-
port vesicles has to be tightly controlled as some
 .molecules ‘cargo’ have to enter the vesicles,
whereas other molecules e.g., resident enzymes of
.the donor compartment have to be excluded. Fur-
thermore proteins that ensure correct targeting of the
vesicle have to be included in order to prevent the
intermixing of the compartments.
Over the last thirty years the data gathered by
diverse techniques comprising cell-free assays,
molecular genetics, morphology and microinjection
have revealed some principal similarities in the for-
mation of transport vesicles. In the best studied cases
formation of a vesicle requires recruitment of coat
proteins from a cytosolic pool to the donor membrane
w x4 . Assembly of the coat is at least in a number of
cases regulated by and dependent on a small
w xmonomeric GTPase of the ARF-family 5 . The poly-
merization of the coat is thought to provide the
driving force required to shape a flat membrane into
a curved bud, although it has been proposed that an
asymmetrical distribution of acidic phospholipids
might be needed to bring about the necessary curva-
 w x.ture membrane-bilayer couple hypothesis 6 . In the
special case of secretory granules the biophysical
properties of the cargo proteins provide an additional
mechanism for the shaping of a vesicle: The interac-
tion of a large particle consisting of aggregated cargo
with the lumenal face of the donor membrane is
thought to cause the membrane to envelop the cargo
particle and result in the formation of a vesicle in
analogy to the budding of an enveloped virus.
More recent data on the formation of vesicles have
arisen in large part from genetic and biochemical
studies on the vesicles that govern transport between
the ER and the Golgi as well as within the Golgi
 . w xCOP I and more recently COP II 4 . Although the
anterograde nature of one class of these vesicles
 . w xCOP I-vesicles is currently being reassessed 7 , it
would be difficult to review this field without ac-
knowledging the important new discoveries coming
from the study of these vesicles. The first part of this
review is therefore focused on the similar and special
aspects of the formation of COP I- and COP II-coated
vesicles.
Whereas proteins leaving the endoplasmic reticu-
lum are thought to be directed without exception to
the Golgi complex, the sorting process at the trans-
 .side of the Golgi, in the ‘trans-Golgi network’ TGN
is far more complex due to the multitude of intra-
w xcellular destinations that are fed from this site 8 .
Lysosomal enzymes are bound by the MPR which is
w xrecruited into clathrin-coated pits 9 . These pits form
clathrin-coated vesicles that bud from the TGN and
fuse with an endosomal compartment. In contrast,
secretory proteins are sorted into distinct carriers.
 .Little is known about the vesicular carrier s trans-
porting constitutively secreted proteins to the plasma
membrane although two new types of coat have
( )S. Urbe et al.rBiochimica et Biophysica Acta 1358 1997 6–22´8
w xrecently been described on the TGN 10–12 . One
reason for the relatively slow progress on the consti-
tutive secretory pathway lies in the lack of appropri-
ate endogenous marker molecules. In specialized cell
types such as endocrine, exocrine, neuroendocrine,
and others a specialized form of secretion, which is
regulated by external factors, leads to a requirement
for a third pathway — the regulated secretory path-
way. This pathway exists in parallel with the pathway
to endosomes and the constitutive secretory pathway
which also originate from the TGN. The regulated
secretory proteins are packaged into secretory gran-
ules in a process that is thought to involve selective
aggregation of the cargo-molecules and for which a
w xcargo-receptor has yet to be identified 13 . The
formation of secretory granules will be the second
subject addressed in this review.
3. COP I- and COP II-coated vesicle formation
A number of theories have been put forward to
explain the process by which secretory molecules,
both proteins and lipids, leave the ER and are trans-
ported to their correct subcellular destination or are
secreted in the case of soluble secretory proteins. All
of these theories have in common that they require
the production of vesicles, either to transport material
forward through the Golgi or to retrieve it back to the
ER. Here we shall briefly discuss first the bulk-flow
w xhypothesis 14 and second the view of the secretory
w xpathway as a maturing system 15 .
In the bulk flow hypothesis the organelles of the
 .secretory pathway ER and Golgi are seen as com-
partments through which material passes but which
are themselves stable, defined structures. Secretory
content is not selected for transport, but once cor-
rectly folded and glycosylated is able to escape the
retrieval machinery of the ER and exit in vesicles
which deliver their content to the Golgi. Once in the
Golgi a variation on this theme carries the molecules
from one cisterna to the next until they reach their
final destination. Thus bulk-flow implies that like a
tree branch falling into a river, a molecule entering
the secretory pathway will be carried along with the
flow until it either reaches a ‘sink compartment’ the
plasma membrane or the extracellular medium in the
.  .case of secretion or it becomes ‘stuck’ retained at
some point. In a modified version of this model,
secretory molecules are selected for transport from
the ER but not for trafficking through the Golgi. This
is suggested by evidence that the concentration of
secretory molecules is up to ten-fold higher both at
sites of vesicle budding on ER membranes as well as
w xin the Golgi than it is in the bulk of the ER 16,17 .
The ‘maturation’ view of the secretory pathway
sees the Golgi as a more transient structure, a collec-
tion of transport intermediates between the ER and
the plasma membrane. Secretory content and Golgi
enzymes are transported from the ER in vesicles
which fuse with one another to form the cisternal
structures characteristic of the Golgi complex. These
structures then mature as material to be retained
 .such as Golgi enzymes is transported in vesicles
back to the ER. When this process is complete they
finally fuse with the plasma membrane and deliver
their content. This model has been used to explain
how material too large to be packaged into small
vesicles is transported through the secretory pathway.
In the next section we will describe the two known
classes of vesicles that are associated with the ER
and the Golgi complex. Although, as we shall see, a
lot of information has been gathered concerning the
formation of these vesicles, their existence and char-
acteristics are compatible with either of the two
views described above.
3.1. COP I-coated ˝esicles
COP I-coated vesicles were first described in the
intra-Golgi transport assay developed by Rothman et
w xal. 18 . In this assay their formation was observed
when Golgi membranes were incubated in the pres-
ence of cytosol, fatty acyl-coenzyme A, and nu-
w xcleotides 18,19 . They could be accumulated under
certain conditions known to block protein transport in
vitro such as the addition of non-hydrolysable GTP
w xanalogues 20 . This lead to the hypothesis that these
were the vesicles mediating forward transport through
the Golgi complex. Subsequently these vesicles, now
known as COP I vesicles, were purified to homogene-
w xity 21 and the cytosolic components forming their
w xcoat characterized 22–24 . The complex these com-
ponents form in the cytosol was named the ‘coatomer’
and consisted of 7 polypeptides plus the small GTP-
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binding protein ARF1 that is not part of the coatomer
 .itself Table 1 .
Many of these proteins have also been described in
yeast arguing that the formation of COP I vesicles is
by a conserved mechanism. The components required
to form COP I vesicles from Golgi membranes have
now been defined as the coatomer, ARF, GTPg S,
w xand fatty acyl-coenzyme 25,26 . The role of ARF is
thought to be in recruiting the coatomer present in a
cytosolic pool to the membrane from which the vesi-
cle is destined to bud. Binding of ARF to membranes
is regulated by its nucleotide state, the GDP form
being cytosolic and the GTP form membrane bound
w x27 . This nucleotide exchange process is under the
control of a peripheral membrane protein of the Golgi
w xand is inhibited by the drug brefeldin A 28,29 . A
candidate for the ARF-GEF has recently been identi-
fied, it is a protein of 619 kDa containing two motifs
similar to the Ran-GEF RCC1 and was localized to
w xthe Golgi by immunofluorescence 30 . The role of
this exchange factor in vesicle traffic is unclear at
present since it is not specific for ARF, and its
GDP-GTP exchange activity toward ARF was not
shown to be sensitive to brefeldin A.
There is some evidence that ARF plays a structural
role in the vesicle rather than merely acting to regu-
late coat recruitment during vesicle budding, since
vesicles produced in the presence of GTPg S have a
w x3:1 ratio of ARF to coatomer 22 . However, more
recent findings indicate that COP I-coated vesicles
containing no ARF can be produced under certain
w xconditions 31 , implying that it is not an essential
structural component of the vesicle. How then do we
explain the discrepancy between this somewhat
heretical observation and the data suggesting that
ARF is a structural component of COP I-coated
vesicles? Consideration of another class of vesicle
known to be involved in transport between the ER
and Golgi complex and the factors involved in its
formation may shed some light on this problem.
Table 1
 .COP I- and COP II-coated vesicle formation proteins see text for references
Description Function
COP I:
a-COPrRet1p form 700-kDa cytosolic complex structural components of the COP I coat recruited
known as the coatomer from the cytosol
b-COPrSec26p
Xb -COPrSec27p
g-COPrSec21p
d-COP
e-COP
z-COP
ARF1 cytosolic small GTP-binding protein recruitment of COP I to membranes
ARF-GAP cytosolic protein GAP activity toward ARF
p619 peripheral Golgi membrane protein putative ARF-GEF
COP II:
Sec13p form a 700-kDa hetero-oligomer COP II structural components
Sec31p
Sec23p form a 400-kDa hetero-oligomer coat component with GAP activity toward SAR1
Sec24p
Sar1p cytosolic small GTP-binding protein recruitment of COP II to membranes
Sec12p resident membrane protein of the ER GEF activity toward SAR1
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3.2. COP II-coated ˝esicles
The second class of vesicle, discovered more re-
cently, is the COP II vesicle identified by a combina-
tion of first genetic then biochemical means in the
w xyeast Saccharomyces cere˝isiae 4 . These vesicles
mediate the transport of a subset of secretory proteins
from the ER to the Golgi complex. The components
required to form the COP II vesicle are recruited
from the cytosol, and include the small GTP-binding
protein Sar1p and two protein complexes formed
from the Sec13rSec31 and Sec23rSec24 gene prod-
 . w xucts Table 1 32 . In addition a membrane protein,
the product of the Sec12 gene, has been identified as
the exchange factor triggering nucleotide exchange
w xon Sar1p 33 . A COP II-coated vesicle will form
from ER membranes when the Sar1p exchange factor
 .Sec12p is activated, this leads to binding of Sar1p-
GTP to the membrane and recruitment of the Sec13p
w xand Sec23p COP II coat subcomponents 32 . The
Sar1p then hydrolyses its bound GTP stimulated by
the Sec23p protein which has GAP activity toward it,
and is then released from the growing vesicle bud
leaving the coat molecules behind. If the non-hydro-
lysable GTP analogue GMP–PNP is used instead of
GTP the Sar1p is not released from the membrane
and instead becomes incorporated into the vesicle,
being present at almost twenty-fold the level com-
w xpared to vesicles budded in the presence of GTP 32 .
3.3. ARF and SARI
Returning to the COP I-coated vesicle and the
problem of whether or not ARF is present as a
structural component. It now seems that like COP
II-coated vesicles, they do not contain their small
GTP-binding protein unless formed in the presence of
w xnon-hydrolysable GTP analogues 31 . Therefore the
presence of ARF or Sar1p in COP I- and COP
II-coated vesicles, respectively, could be seen as
misleading since the coat does not have an absolute
requirement for their presence once it is bound to the
membrane. What do ARF and Sar1p do if their role
in vesicle formation is not to stably bind the coat to
the membrane?
An alternative model, based on the available data
describing the formation of the COP II-coated vesi-
cle, would be that activation of the membrane associ-
ated ARF-GEF or Sar1p-GEF at the site from which
the vesicle is to bud leads to recruitment of the
appropriate small GTP-binding protein. The coat
molecules would then be recruited to the membrane
either directly by interaction with the small GTP-bi-
Fig. 1. Model for the formation of a COP I- or COP II-coated vesicle. Activation of a membrane associated GEF leads to recruitment of
 .  .the small GTP-binding protein ARF or Sar1p to the bud site. Subsequently coat molecules COP I or COP II are recruited to the
membrane where they interact laterally with one another, the small GTP-binding protein then hydrolyses its bound GTP and is released
into the cytosol. At the edges of this growing coat patch there is a cap of the GTP form of the small GTP-binding protein which prevents
coat depolymerisation. As the coat grows it deforms the membrane leading to the formation of a vesicle bud, which can then be pinched
off in a final scission step.
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nding protein or indirectly. In the case of ARF this
indirect recruitment could be by a phospholipase D
 .PLD mediated pathway involving the local genera-
tion of acidic phospholipids such as phosphatidic
acid, which have been shown in vitro to increase the
w xbinding of coatomer to liposomes 31 . Treatment of
Golgi membranes with bacterial PLD bypasses the
requirement for activated ARF in coatomer binding
w x31 , providing further evidence that ARF acts on
coat recruitment by this mechanism. Following initial
membrane-binding, coat molecules would interact lat-
erally and start to deform the membrane. Release of
the small GTP-binding protein would then be trig-
gered by the activation of some specific GAP activ-
w xity, Sec23p in the case of Sar1p 34 and presumably
w xfor ARF the recently identified cytosolic GAP 35 .
Once in the cytosol the ARF or Sar1p would then be
free to recruit more coat to the growing vesicle bud,
such a cycle would be driven by nucleotide exchange
and opposed by nucleotide hydrolysis. Thus vesicle
coat formation in this model could be seen as analo-
gous to microtubule polymerisation, in that a cap of
ARF-GTP COP I or Sar1p-GTP COP II subunits
would exist at the growing edge of the coat. So long
as the rate of ARF or Sar1p activation were high
enough this process would continue until the vesicle
 .had fully budded Fig. 1 .
3.4. Cargo and selection
The process by which cargo is selected for incor-
poration into COP I- and COP II-coated vesicles is
still poorly understood. For the COP I-coated vesicle
it has been shown using a combination of genetic and
biochemical methods that type I transmembrane pro-
teins containing a dilysine motif require COP I for
w xtheir retrieval from the Golgi back to the ER 36 .
Biochemical studies have shown that the dilysine
motif can specifically bind to the coatomer in the
absence of any other components, including ARF
w x37 . Although it is unclear if this interaction is
involved in stabilising the binding of coatomer to the
membrane, or recruiting the cargo protein to the COP
I-coated bud, or possibly even both. COP I-coated
vesicles produced from rat liver Golgi in vitro in the
presence of GTPg S do not contain significant amounts
 .of soluble secretory serum albumin or transmem-
 .brane polymeric IgA receptor proteins, but do con-
tain significant amounts of proteins recycling be-
tween the ER and Golgi complex such as the KDEL
 .receptor Erd2p and p58, a mannose specific lectin
w x38 . In yeast, COP I vesicles produced in vitro from
nuclear envelope and ER with purified components
w x 39 do not contain the soluble secretory proteins pro
.  .a-factor or ER residents Kar2p, Sec61p, Sec12p
 .but do contain vesicle targeting proteins Sec22p .
Together these observations have caused much specu-
lation on the direction in which the COP I-coated
vesicle is transporting material, anterograde: from the
ER to the Golgi and forward through the Golgi, or
retrograde: backwards through the Golgi and to the
ER from the Golgi. Some evidence exists they can
mediate forward transport from the ER since COP
I-coated buds can be formed on isolated nuclear
w xenvelopes and ER remnants 39 . One possible expla-
nation for the apparent lack of cargo in COP I-coated
vesicles produced in vitro is that GTPg S acts to
uncouple coat recruitment from the cargo selection
process. COP II-coated vesicles have been shown to
 .transport secretory proteins pro a-factor , GPI-
 .anchored proteins Gas1p , transmembrane proteins
 .such as amino acid permeases Hip1p and Gap1p ,
and to contain vesicle targeting proteins Sec22p,
. w xBos1p, Bet1p in yeast 32,39 . While in mammalian
cells they have been shown to be responsible for the
transport of VSV-G protein from the ER. In summary
the current data support the view that COP I vesicles
mediate retrograde traffic within the Golgi and from
the Golgi to the ER, while COP II vesicles mediate
transport from the ER to the Golgi.
3.5. Cargo and the site of bud formation
How the choice of the site for vesicle budding is
made is still unknown. For COP II vesicles this
process is thought to involve the Sar1p-GEF, the
sec12 protein. One possibility is that the GEF func-
tion of Sec12p could be regulated, being activated
only when and where a vesicle needs to be budded.
However, there is no evidence at present that the
GEF function of Sec12p is regulated in such a man-
ner, in fact it has been shown that the recombinant
protein has constitutive GEF activity toward Sar1p
although this does not rule out negative regulation of
Sec12p in vivo. Another possibility is that a local
concentration of Sec12p is needed to lead to suffi-
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cient Sar1p being recruited to the membrane in order
to start the vesicle formation process.
What then would initiate the vesicle formation
process? It has been proposed that the presence of
sorted cargo acts as a signal for the formation of a
w xvesicle 40 . For the COP I-coated vesicle the p24
family of putative cargo receptors has been identified
which contain a motif in their cytoplasmic domains
w xthat can interact with the coatomer in vitro 40 .
Whether or not these proteins can in the presence of
some cargo molecules actually signal for a vesicle to
be made, or are simply passengers in the vesicle is
not known. Interestingly, there is some evidence that
the binding of coat molecules to the membranes is
regulated by heterotrimeric G-protein and second
w xmessenger signalling pathways 41,42 , leading to the
possibility that these are involved in the decision to
make a vesicle. For COP II-coated vesicles in yeast
there is no absolute requirement for a cargo-depen-
dent signal, since these vesicles can still be produced
when the ER lumen is emptied of cargo molecules
w x43 . These experiments also showed that the ER
chaperone BiP is not required for vesicle budding.
However, transport of some proteins by COP II-coated
vesicles does require a membrane protein of the p24
class of putative cargo receptors since deletion of the
emp24 gene results in a decrease in the rate of
w xtransport of these proteins from the ER 44 .
In summary, while packaging of some cargo in to
COP I- and COP II-coated vesicles requires cargo
receptors of the p24 family these are unlikely to
signal for a vesicle to be made but rather act to
sequester cargo to the vesicle.
4. Formation of regulated secretory vesicles
The mechanisms involved in the formation of se-
cretory granules from the TGN are not yet known
and the current hypotheses are based on principles
 . w xproposed over 10 years ago by Kelly 1985 45 :
selection and exclusion. Secretory granule formation
requires selection of soluble and membrane proteins
into nascent secretory granules, and exclusion of
proteins not required for the function of secretory
granules. Current research remains focused on the
mechanisms involved in the lumenal sorting of solu-
ble secretory proteins including the identification of
‘signals’ which mediate active sorting of components
into secretory granules. Recently the temporal se-
quence of the sorting events has gained much atten-
tion, as summarized by the alternative but not mutu-
ally exclusive ‘sorting for entry’ vs. ‘sorting by
w xretention’ models 46 . ‘Sorting for entry’ which en-
compasses the most popular models requires selec-
tion of cargo and membrane in the TGN prior to ISG
formation, whereas ‘sorting by retention’ stipulates
that there is little selection in the TGN prior to
granule formation. Rather secretory granule specific
components are retained during maturation of the
granule while missorted molecules defined as those
.not retained are removed only at a later stage from a
post-TGN compartment, presumably by vesicles bud-
ding from the ISG. A second area of active research
concerns the identification of cytosolic components
involved in the budding of secretory granules from
the TGN. The majority of this research is facilitated
by the use of in vitro cell systems, or reconstitution
assays consisting of isolated membranes and cytosol
and has led to several important observations con-
cerning the cytoplasmic machinery involved in secre-
tory granule formation.
The recent progress in secretory granule formation
will be reviewed in four sections which mirror the
temporal sequence of events during secretory granule
formation: aggregation, sorting signals, vesicle for-
mation, and post-TGN sorting.
4.1. Aggregation of soluble secretory proteins as a
means to promote sorting
One mechanism for sorting soluble secretory pro-
teins both before, and after, entry into secretory
granules, is via aggregation or condensation see
.below of a subset of soluble proteins to the exclu-
sion of other soluble, non-aggregating secretory pro-
teins. For efficient aggregation the local concentra-
tion of the secretory proteins should be high in the
sorting compartment. Soluble secretory granule pro-
teins are for the most part very abundant in cells with
a regulated secretory pathway. A family of proteins
w xknown as the granins in particular 47 are highly
expressed in most endocrine and neuroendocrine cells.
The members of this family of proteins include chro-
 .  .mogranin A CgA , chromogranin B CgB , secre-
 .togranin II SgII , secretogranin III, and secretogranin
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 .IV also known as 7B2 and have similar structural
features which may enable them to aggregate in the
w xlumen of the secretory pathway 48 .
Aggregation of SgII has been shown in vitro as
well as in permeabilized TGN membranes in the
presence of a low-pH, high-Ca2q buffer, conditions
believed to mimic the lumenal environment of the
w xTGN 49,50 . Other soluble secretory proteins, other
members of the granin family and other proteins
found in secretory granules, have also been shown to
aggregate under these low-pH, high-Ca2q conditions
 w x.see, e.g., 51,52 . Indeed, morphological evidence
demonstrating the presence of aggregates of regulated
w xsecretory proteins in the TGN 53,54 , but not in
earlier compartments under normal conditions sup-
ports the role of aggregation in sorting. In contrast,
results obtained with streptolysin O-permeabilized
PC12 cells suggest that free Ca2q may not be crucial
for sorting of regulated secretory proteins in the TGN
w x55,56 . Interpretation of all these results to determine
the precise role of pH and Ca2q in the TGN requires
accurate measurements for pH and Ca2q in the lumen
of the TGN in regulated secretory cells. Whereas
values for the pH in the TGN of cells lacking a
regulated secretory pathway have been proposed in
 .two recent studies 6.17"0.02 and 6.45"0.03
w x57,58 there are still no data available on the free
Ca2q concentration prevailing in the lumen of the
TGN.
There exists some controversy concerning the loca-
tion and role of the aggregation event which may
relate to differences between the cellular systems
 .studied Fig. 2 . The b-cells of the endocrine pan-
creas secrete large quantities of insulin for review,
w x.see 59 . Mature insulin forms insoluble, close-
packed crystalline arrays in the presence of zinc,
whereas proinsulin has distinct physical properties
which prevent its condensation into insoluble aggre-
gates. Processing of proinsulin to insulin, which re-
quires two processing enzymes, called PC enzymes 1
and 2, acting at two distinct sites for review, see
w x.13 , is therefore crucial for the condensation of
insulin. Hence the site of proinsulin processing be-
comes critical for a sorting mechanism that relies on
exclusion of soluble proteins. Some reports suggest
that processing of prohormones by PC-enzymes can
w xbegin in the TGN 60–62 , whereas other studies
w xindicate that processing is initiated in the ISG 63–65 .
 .Fig. 2. Model illustrating the ‘sorting by retention’ A and
 .‘sorting for entry’ B hypotheses. Lysosomal enzymes are indi-
cated as an example for proteins that are sorted away from
 .secretory granule proteins. In A the bulk of the lysosomal
 .enzymes and other non-granule-proteins are sorted only after
 .formation of the ISG. In B the bulk of the sorting is achieved in
the TGN prior to formation of the ISG.
Proinsulin conversion has been demonstrated to only
w xoccur in secretory granules 66–68 and references
.included therein . If sorting of hormones relies on
exclusion of soluble non-granule material through
aggregation or condensation, the sorting of insulin
can only take place in a post-TGN compartment.
These results have provided the basis for the ‘sorting
 .by retention’ hypothesis Fig. 2A .
On the other hand, the data to support the ‘sorting
for entry’ hypothesis, where the bulk of sorting has
been demonstrated to occur prior to formation of an
 . ISG, is equally compelling Fig. 2B see references
.above . To reconcile these two hypotheses, we sug-
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gest that whether sorting is predominantly TGN-based
 .  .sorting for entry or ISG-based sorting by retention
might depend both on the propensity of the prohor-
mone to aggregate, or not, and the relative rates of
prohormone synthesis and vesicle formation in the
TGN.
In endocrine, neuroendocrine or neuronal cells ag-
gregation as a mechanism to promote sorting may
have evolved to compensate for the diversity in pro-
hormone structure, in particular for prohormones
which encode multiple hormones e.g., POMC-de-
rived hormones such as ACTH, b-MSH, etc., ELH-
derived hormones such as bag cells peptides for
w x.review, see 69 . If sorting of an aggregate of secre-
tory proteins does not rely on a specific and stochio-
metric receptor–ligand interaction, efficient sorting
of prohormones with a less than optimal ability to
condense, or which are present at very low concentra-
tion, might be enhanced by ‘helper proteins’ that aid
w xaggregate formation 70 . Recently, Natori and Hut-
w xtner 62 have demonstrated that increasing the amount
of CgB in AtT20 cells a cell line derived from the
.pituitary corticotroph indeed promoted efficient sort-
ing of the 23-kDa POMC fragment into secretory
granules, resulting in increased storage of the 23-kDa
POMC fragment and ACTH.
4.2. Sorting signals as a means to promote sorting
Budding of secretory granules from the TGN can
be seen as largely analogous to the budding of virus
particles from the plasma membrane but with inverse
topology. Recruitment of the viral membrane is
achieved by the interaction of the viral coat proteins
 .in the plasma membrane with the matrix proteins
 .in the cytoplasm . By analogy, the secretory granule
 .membrane proteins in the TGN membrane must
 .interact with the granule content in the TGN lumen .
Indeed, there must be a recognition mechanism be-
tween soluble granule proteins and granule mem-
brane proteins or components to ensure that the mem-
brane which finally envelops the core contains all the
proteins necessary for secretory granule maturation,
storage and exocytosis.
The paradigm for sorting of soluble proteins into
vesicles is receptor-mediated endocytosis at the
plasma membrane: a receptor binds a ligand, and
sequesters the ligand for transport to a different com-
partment in a coat-dependent fashion. This model has
been extended to a variety of intracellular transport
events including sorting of regulated secretory pro-
teins in the TGN. Regardless of whether a single
molecule or a molecular aggregate is sorted, this
paradigm has remained attractive enough for investi-
gators to continue to pursue the putative ‘sorting
receptor’. This putative sorting receptor could then
interact directly or indirectly with the cytosolic ma-
chinery involved in the vesicle formation.
Recent experiments have focused on an N-terminal
disulfide loop structure found in POMC, pro-
vasopressin, pro-oxytocin, pro-dynorphin, pro-en-
w xkephalin, CgA and CgB 47,71 . The N-terminal 26
amino acids of POMC have been shown to contain a
signal which sorts a reporter molecule into secretory
w xgranules in AtT20 cells 72 . It has been further
demonstrated that a disulfide bond, within this se-
quence of 26 amino acids, forms an amphipathic loop
structure which may play a role in sorting POMC to
w xISGs 71 . These data are supported by experiments
in which the disulfide bond of CgB was disrupted by
incubation of PC12 cells with DTT, leading to consti-
w xtutive secretion of CgB 73 .
Identification of a putative structural motif in-
volved in the sorting of prohormones to ISGs is only
half of the story. In pursuit of a receptor which would
recognize the sorting motif researchers have used
assays based on the binding of solubilized secretory
granule membrane components to immobilized regu-
lated secretory proteins. As some granule ‘matrix’
proteins such as CgB exist as membrane-bound iso-
w xforms 74 , it has been suggested that the membrane
bound forms of such proteins would act as nucleating
receptors to recruit soluble regulated secretory pro-
w xteins 47 . Indeed, recent experiments have demon-
strated that the membrane associated form of
carboxypeptidase E, a granule specific carboxypepti-
w x w xdase 75 , can function as a sorting receptor 76 .
Alternatively, it could be that other bone fide mem-
brane proteins act as receptors for the aggregate, such
w xas the IP receptor 77,78 identified using the same3
approach with immobilized, soluble CgA.
A variety of exogenous soluble proteins, ranging
from proteins such as renin, normally expressed in
w xthe kidney 79 , to trypsinogen, normally expressed in
w xpancreatic exocrine cells 80 , have been expressed
by transfection in endocrine and neuroendocrine cell
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lines. These exogenous molecules have been found to
be secreted in a regulated fashion from the trans-
fected cells lines, suggesting that these proteins have
been stored in secretory granules. These results cast
doubt on the existence of a single ‘sorting receptor’
because it is difficult to reconcile the accurate sorting
of such a variety of molecules with a single receptor.
w xGerdes et al. 81 have argued that efficient sorting of
these molecules was obtained because the exogenous
molecules were sorted by co-aggregation with the
endogenous regulated secretory proteins. Therefore
identification of a sorting sequence could only be
achieved in essentially a null background of endoge-
nous regulated secretory proteins. They have achieved
this experimentally using a vaccinia virus expression
system which shuts off host protein synthesis, and
have demonstrated that exogenous CgB when ex-
pressed in vaccinia virus infected PC12 cells can be
efficiently sorted to secretory granules but that CgB
 .without the N-terminal disulfide loop Dcys-CgB
was not correctly sorted. Furthermore, in the same set
of experiments the authors demonstrated that Dcys-
CgB was correctly and efficiently sorted after con-
ventional transfection protocols providing additional
support for their hypothesis. Using this powerful
expression system the authors should be able to begin
to identify the requirements for sorting of soluble
proteins to the secretory granule.
4.3. The role of GTP-binding proteins in secretory
granule formation
Unlike the case of COP I- and COP II-coated
 .vesicles see above , the formation of secretory vesi-
cles from the TGN is inhibited by non-hydrolysable
w xGTP-analogues 82 . The same effect was observed
w xywith AlF and several other lines of evidence4
demonstrated that heterotrimeric GTP-binding pro-
teins are involved in the regulation of post-Golgi
 w x.vesicle formation for review, see 83 . What has
only recently become clear is that the monomeric
GTPase ARF also plays a role in the formation of
vesicles from the TGN. Recent reports from two
cell-free assays have implicated ARF in the budding
of secretory granules and post-TGN vesicles. Myris-
toylated ARF1 peptide stimulated both the formation
of secretory granules and constitutive secretory vesi-
w xcles from isolated TGN membranes 84 , while in a
w xsemi-intact cell system 85 ARF1 peptide was suffi-
cient for stimulation of budding of GH- and PRL-
containing vesicles. In addition, the generation of
vesicles from Golgi fractions isolated from MDCK
cells was sensitive to the addition of brefeldin A,
w xsuggesting that ARF was required 86 . ARF is known
to be involved in the recruitment of COP I coats to
 .membranes see above ; however, Barr and Huttner
w x84 could demonstrate that depletion of COP I from
cytosol did not inhibit post-Golgi vesicle formation.
Although coatomer does not seem to be required for
post-Golgi vesicle formation it is possible that ARF
w xis acting through phospholipase D 87–89 and see
w x .5 for review possibly by recruiting another as yet
unidentified coat.
An intriguing related observation concerns the role
of an as yet unidentified cytoplasmic phosphoprotein
 .as a modulator of the heterotrimeric G protein s that
w xregulate vesicle formation from the TGN 90 . This
observation is supported by several other reports
from cell-free budding assays which indicate that
phosphorylation regulates secretory vesicle formation
w x86,91–93 . A role for tyrosine-phosphorylation in
secretory granule biogenesis andror function has also
been suggested by two recent reports that have identi-
fied two highly homologous proteins in the mem-
brane of secretory granules which appear to be non-
functional protein-tyrosine phosphatases, called
w xphogrin and the ICA 512 autoantigen 94,95 .
4.4. The role of phosphatidylinositide metabolism and
secretory granule formation
Further exciting results have been obtained regard-
ing additional cytoplasmic proteins required for vesi-
cle formation from the TGN. A phosphatidylinositol
 .transfer protein PITP has been implicated in the
formation of both regulated and constitutive secretory
w xvesicles 96 . The mammalian PITP activity can be
substituted for by Sec14p, a yeast protein from Sac-
charomyces cere˝isiae not homologous to the mam-
.malian PITP that is required for normal Golgi func-
tion and shares with PITP the ability to exchange
w xphosphatidylinositol for phosphatidylcholine 97,98 .
It has been suggested that PITP may present PtdIns to
various PI-kinases and thus contribute to the local
generation of polyphosphatidylinositols in the mem-
w x w xbrane 99,100 ; for review, see 101 . PtdIns 4-kinase
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 .which generates PtdIns- 4 P from PtdIns is localized
to many intracellular organelles including secretory
w x.  .granules 102 . PtdIns 4,5 P has been implicated in2
w xa variety of membrane traffic events 103 and has
been shown to regulate the nucleotide bound state of
w x w xARF 104,105 and to stimulate PLD-activity 106 .
An intriguing related observation is the finding that
 .PITP and PtdIns- 4 P 5-kinase act synergistically,
 .presumably through the generation of PtdIns 4,5 P ,2
in a semi-intact cell assay reconstituting fusion of
secretory granules with the plasma membrane
w x107,108 . It will be very interesting to see whether a
 .PtdIns- 4 P 5-kinase activity is required in vesicle
formation from the TGN to complement the finding
that PITP is required and whether PtdIns-metabolites
 .other than PtdIns 4,5 P are involved in the budding2
from the TGN.
PtdIns is also the substrate for the yeast kinase
w xVps34 which has PI 3-kinase activity 109 . The
 .synthesis of PdtIns 3 P by Vps34 has been implicated
in the transport from the Golgi to the vacuole in yeast
and it has been suggested that Vps34 activity is
required for the formation of a specific vesicle type
w xfrom the Golgi 110 . A wortmannin-sensitive PI
3-kinase activity is also required for the sorting of
lysosomal enzymes from the Golgi to the endosome
w x w xin mammalian cells 111,112 and see 113 for
.review . To our knowledge there has been no report
implicating a PI 3-kinase in the budding of regulated
secretory granules, indicating that the role of PI
3-kinase activity in sorting andror in vesicle forma-
tion is restricted to the transport from the Golgi see
.references above and the plasma-membrane
w x114,115 to the endosome. In fact, we have been
unable to observe any effect of wortmannin on either
constitutive or regulated secretory vesicle formation,
transport and exocytosis in PC12 cells S. Urbe and´
.S.A. Tooze, unpublished observations .
With regard to the role of PtdIns-metabolites in
vesicle formation, it is of interest that a 105-kDa
protein belonging to the inositol 5-phosphatase fam-
ily has recently been localized to the Golgi complex
w x116 . This protein, the gene product of the oculo-
 . w xcerebrorenal syndrome of Lowe OCRL 117 , de-
 .  .phosphorylates Ins 1,3,4,5 P , Ins 3,4,5 P and most4 3
 .importantly PtdIns- 4,5 P in vitro, and seems to act2
preferentially as a lipid-phosphatase in vivo. OCRL
 .could therefore regulate the levels of PtdIns- 4,5 P2
w xin the Golgi-membrane 118 . Another inositol-5-
phosphatase, synaptojanin, has been implicated in the
recycling of synaptic vesicles, a process that involves
w xthe formation of clathrin-coated vesicles 119 .
w xSynaptojanin interacts through amphiphysin 120
with the small GTPase dynamin which appears to
play an important role in the budding of clathrin-
coated vesicles from the plasma-membrane for re-
w x.views, see 121–123 . Although the function of dy-
w xnamin has predominantly, but not exclusively 124 ,
been linked to the function of clathrin, it has been
speculated that there might be a dynamin for every
w xbudding event in the cell 125 . Interestingly vps1,
another vacuolar protein sorting mutant in yeast that
is defective in transport of proteins from the Golgi to
the vacuole has amino-terminal homology 45% iden-
. w xtity to the mammalian dynamins 126 . More re-
cently a protein with immunoreactivity to antibodies
raised against conserved regions of the dynamin-
family has been localized to the Golgi complex in
w xfibroblasts and melanocytes 127 . As GTP-hydroly-
sis is required for dynamin function it is possible that
the inhibitory effect of GTPg S on the budding of
secretory vesicles from the TGN reflects not only an
involvement of heterotrimeric G proteins but also of
dynamin.
4.5. Post-TGN sorting and ˝esicle formation from the
ISG
Secretory granules are by definition an intra-
cellular storage compartment whose function is to
allow the controlled and rapid release of secretory
proteins. It is, therefore, of great importance that the
final composition of the stored molecules is verifi-
able. The current hypothesis and recent data concern-
ing the formation of secretory granules demands a
post-TGN sorting mechanism to accomplish verifica-
tion of the secretory granule content concomitant
with initiation of storage. As mentioned above, the
extent of the post-TGN sorting remains a controver-
sial point.
The evidence for post-TGN sorting events is de-
 .rived from a variety of morphological Fig. 3 and
 w x.biochemical observations for reviews, see 128,129 .
Post-TGN sorting events could encompass several
 .independent trafficking pathways: 1 a ‘constitutive-
like’ pathway to the plasma membrane which re-
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 .Fig. 3. Micrographs of serial sections A–F of an ACTH-containing ISG lying close to a Golgi stack in AtT20 cells. The arrow indicates
w xa coated vesicle budding from the ISG. Bar, 0.1 mm. Reprinted with permission from the Journal of Cell Biology 54 .
 .moves soluble non-aggregated secretory molecules
 .from the maturing ISG; 2 a recycling pathway back
to the TGN either to allow maximal usage of proteins
involved in granule-formation or recycling of TGN-
 .resident proteins; and 3 a pathway to the endosomal
system for removal of lysosomal proteolytic enzymes
from the ‘precious’ granule protein cargo. Although
still not a proven fact, it has long been suggested that
the patches of clathrin detected on the surface of
ISGs could be involved in the generation of clathrin-
coated vesicles from the ISG rather than in the
budding of the ISG from the TGN. The formation of
an ISG-derived vesicle would be required by any of
these post-TGN sorting events and would result in
remodelling of the secretory granule membrane.
It is possible that the clathrin patches on the
forming ISG in the TGN reflect in part the segrega-
tion of proteins in the TGN that are required for both
ISG and endosome function. The secretory granule
w qxproton-pump, the vacuolar H -ATPase, for exam-
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ple, shares several subunits with the endosomal coun-
w xterpart 130 and might utilize a single mechanism
 .clathrin-adaptor-dependent recruitment for exit from
the TGN into both ISGs and endosome-directed
clathrin-coated vesicles. Once in the ISG, an addi-
tional mechanism would then be required to retain
these proteins within the maturing secretory granule
and prevent their removal by clathrin-coated vesicle
formation from the ISG. One such mechanism might
involve the granule specific transmembrane subunit
w qx w xof the vacuolar H -ATPase, called Ac45 131 ,
whose function remains to be shown. It is tempting to
speculate that Ac45, which has a large luminal, acidic
domain might interact with the aggregated granule
core thus tethering the proton pump to the core and
preventing its removal in clathrin-coated vesicles. In
this model, the interaction of the Ac45 with either the
proton pump or with the core can only occur once the
ISG is formed.
Formation of clathrin-coated vesicles from an or-
ganelle requires excess membrane. Some ISGs may
have sufficient excess membrane to allow clathrin-
coated vesicle formation and thus membrane retrieval
would lead to a decrease in the secretory granule size
 w x.for review, see 13,132 . However, it has also been
shown that in some cells the size and density of the
w xISG increases during storage 133 . This and the
observation of irregularly shaped ‘fusing’ granules
with multiple cores on EM-micrographs suggest that
ISGs may fuse homotypically in the course of matu-
 w x.ration for review, see 128 . Homotypic fusion of a
different type of secretory granule has been observed
w xin mast cells and eosinophils 134,135 . Fusion of
ISGs would generate additional excess membrane
and allow for the formation of several clathrin-coated
vesicles we calculated that up to 7 clathrin-coated
.vesicles can be formed after fusion of 3–5 ISGs and
 .a net increase in size Fig. 4 . We recently suggested
that the observed acidification of an ISG from a pH
w xof approximately 6.3 in the ISG 65 to a pH of about
w x5.5 in the mature secretory granules 136,137 might
be a direct consequence of these membrane remod-
elling events. Vesicle formation from the ISG could
result in the removal of components that oppose
 q q w x.acidification e.g., Na rK -ATPase 138,139 and
an increase in the concentration of secretory granule
w qxconstituents, including the vacuolar H -ATPase.
Although the ISG-derived clathrin-coated vesicles
Fig. 4. Homotypic fusion of ISGs results in an excess of mem-
brane that can be retrieved by clathrin-coated vesicle formation
from the ISG. Proteins removed from the secretory granules may
be recycled to the TGN, targeted to the endosome or secreted in a
constitutive-like way.
have not yet been identified it can be presumed that
they will not contain any molecules required forsecre-
tory granule function or secretion. Candidate cargo
 .proteins e.g., lysosomal enzymes have been de-
tected in the medium after stimulation of exocrine
w x w xgranules 140 , endocrine glands 46 and endocrine
w xcells 141 . The stimulated release of lysosomal en-
zymes from the endocrine pancreas was observed
only at ‘early’ times after ISG formation, suggesting
that the lysosomal enzymes were removed only from
the maturing secretory granule most probably in a
w xMPR-dependent fashion 46 . The MPR is known to
be sequestered into clathrin-coated vesicles at the
w xplasma membrane 9 and indeed also interacts with
the AP-1 adaptor complex that recruits the clathrin
w xcoat on the TGN membrane 142 . Clathrin coat
formation on ISGs can be reconstituted in vitro using
isolated ISGs, requires both GTP and ARF and is
w xmediated by the AP1-adaptor complex 143 . Prelimi-
nary data using this assay suggest that the MPR is
one of the molecules involved in binding AP1 to
ISGs A.S. Dittie and S.A. Tooze, unpublished obser-´
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.vations . Although coat formation has been reconsti-
tuted in vitro, there are no reports to date of experi-
ments which have unequivocally identified or iso-
lated ISG-derived clathrin-coated vesicles.
5. Conclusions
Reconstitution of secretory vesicle formation in
cell-free assays and analysis of yeast mutants with
secretory defects have provided insights into many
aspects of this important step in membrane traffic.
While the coat components involved in the formation
of COP I and COP II vesicles have been character-
ized in great detail, little is known about the role of
cargo selection in the process of COP-coated vesicle
formation. COP-coated vesicle formation could be
coupled to cargo-sorting through transmembrane sig-
nalling events or proceed independently of cargo
selection. In contrast, research on secretory granule
biogenesis has revolved to a large extent around the
role of the granule content selection. The only coat
proteins identified so far on the secretory granule
 .clathrin and adaptor-complex AP1 are thought to
mediate vesicle formation from the ISG rather than
formation of the ISG from the TGN. It has been
suggested that budding of secretory granules does not
require any coat proteins but that the aggregated core
of the granule is able to ‘drive’ vesicle formation in a
way analogous to the budding of a viral particle. This
hypothesis predicts that there have to be specific
interactions between the granule core and the granule
membrane that mirror the binding of viral nucleocap-
sid proteins to the membrane-bound envelope pro-
teins. In this way the secretory granule core could
mould its own vesicle, driven only by a thermody-
namically favourable binding of granule membrane
proteins with soluble aggregated content. Work on
this sorting mechanism is in progress and it will be
interesting to see whether any of the above specula-
tions hold true. One major unanswered question is
what mediates the scission of the vesicle neck both in
the case of COP-coated vesicle and secretory granule
formation. Dynamin has been proposed to play this
very role in the formation of endocytic clathrin-coated
vesicles. However, no dynamin-like protein has yet
been associated with the budding of either COP-
coated vesicles or post-TGN secretory vesicles.
The most remarkable feature of the last couple of
years in the field of vesicular transport has undeni-
ably been the merger of classical signal transduction
and membrane traffic. After the discovery of the
GTPases as major players in the regulation of many
aspects of membrane transport, the realisation that the
phosphoinositite metabolism is intricately linked to
the same cellular functions has been a major influ-
ence in the field of vesicle formation and will most
likely be the focus of the coming years.
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